Joseph R. Young - 16 Feb 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
SVP, Finance, Chief Acct Offcr
Signature
/s/ Joseph R. Young
Issuer symbol
VERA
Transactions as of
16 Feb 2022
Net transactions value
$0
Form type
4
Filing time
18 Feb 2022, 15:10:21 UTC
Previous filing
17 May 2021
Next filing
23 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +36,729 $0.000000 36,729 16 Feb 2022 Class A Common Stock 36,729 $20.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 16, 2022, subject to continuous service of the Reporting Person on each vesting date.